Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Leukemia 23Prostatic Neoplasms 12Lymphoma 11Burkitt Lymphoma 9Lymphoma, Large B-Cell, Diffuse 4Myelodysplastic Syndromes 3Lymphoma, Non-Hodgkin 3Lymphoma, Large-Cell, Immunoblastic 3Leukemia, Myeloid, Acute 3Leukemia, Biphenotypic, Acute 3Dendritic Cell Sarcoma, Interdigitating 3Anemia, Refractory, with Excess of Blasts 3Recurrence 2Multiple Myeloma 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Follicular 2Leukemia, Myelomonocytic, Chronic 2Hodgkin Disease 2Anemia, Refractory 2Stomatitis 1Rhabdoid Tumor 1Pituitary Neoplasms 1Pituitary Diseases 1Pancreatic Neoplasms 1Oral Ulcer 1Neoplasms, Plasma Cell 1Neoplasms 1Myeloproliferative Disorders 1

Interventions

pegaspargase 1palbociclib 1forodesine 1Vincristine 1Prednisone 1Prednisolone 1Methotrexate 1Hydrocortisone 1Everolimus 1Doxorubicin 1Daclizumab 1Cytarabine 1Cyclosporine 1A-dmDT390-bisFv(UCHT1) protein 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, T-Cell × Hydrocortisone × Clear all
NCT03792256 2025-03-21

Palbociclib in Combination With Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LL)

Children's Oncology Group

Phase 1 Completed
12 enrolled 24 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphoid, Recurrence, Leukemia, T-Cell, Lymphoma, T-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡